Nitromifene
Chemical compound
From Wikipedia, the free encyclopedia
Nitromifene (INN; also as the citrate salt nitromifene citrate (USAN), developmental code names CI-628, CN-5518, CN-55945) is a nonsteroidal selective estrogen receptor modulator (SERM) related to triphenylethylenes like tamoxifen that was never marketed.[1] It is a mixture of (E)- and (Z)-isomers that possess similar antiestrogenic activity.[2] The drug was described in 1966.[1] Along with tamoxifen, nafoxidine, and clomifene, it was one of the earliest SERMs.[3]
Other namesCI-628; CN-5518; CN-55945
CAS Number
- 10448-84-7
5863-35-4 (citrate)
| Clinical data | |
|---|---|
| Other names | CI-628; CN-5518; CN-55945 |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C27H28N2O4 |
| Molar mass | 444.531 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nitromifene has been found to dissociate from the estrogen receptor 250-fold faster than estradiol.[4] This may be involved in its antagonistic activity at the estrogen receptor.[4]